Skip to content
10-Q

Quarterly Report

Biostar Angel Stem Cell Corp

0001493152-18-012365

← back to feed
Filed
Aug 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 14, 2018 10.98M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$47.09K
Cash And Equivalents Q2 2018 · Jun 30, 2018 $100
Stockholders Equity Q2 2018 · Jun 30, 2018 −$55.5K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$3K
Current Liabilities Q2 2018 · Jun 30, 2018 $57.65K
Current Liabilities Q2 2018 · Dec 31, 2017 $3K
Total Liabilities Q2 2018 · Jun 30, 2018 $57.65K
Total Liabilities Q2 2018 · Dec 31, 2017 $3K
Current Assets Q2 2018 · Jun 30, 2018 $2.15K
Total Assets Q2 2018 · Jun 30, 2018 $2.15K
Total Assets Q2 2018 · Dec 31, 2017 $0
Net Income Q2 2018 · Jun 30, 2018 −$55.55K
Net Income Q2 2018 · Jun 30, 2018 −$57.55K
Net Income Q2 2018 · Jun 30, 2017 −$3.31K
Operating Income Q2 2018 · Jun 30, 2018 $55.55K
Operating Income Q2 2018 · Jun 30, 2018 $57.55K
Operating Income Q2 2018 · Jun 30, 2017 $3.31K